Skip to main content
. Author manuscript; available in PMC: 2011 Jul 18.
Published in final edited form as: Genet Med. 2010 Apr;12(4 Suppl):S83–S110. doi: 10.1097/GIM.0b013e3181d67e44

TABLE 2. PATENTS ASSOCIATED WITH ATHENA’S COMPLETE ATAXIA PANEL.

The Complete Ataxia Panel test for 11 subtypes of SCA, as well as Friedreich’s Ataxia and Early Onset Ataxia. Listed are the utility of the test and the reference value of normal for each test. CPT codes are also provided.

Genetic
Test
US Patents Assignee
SCA-1 5741645, 5834183 Regents of the University of Minnesota,
Minneapolis, MN
SCA-2 6251589 SRL, Inc., Tachikawa, Japan
SCA-3 5840491 Akira Kakizuka, Kyoto, Japan
SCA-6 5853995, 6303307,
7329487
Research Development Foundation,
Carson City, NV
SCA-7 6280938, 6514755,
7118893
Regents of the University of Minnesota,
Minneapolis, MN
SCA-8 6524791 Regents of the University of Minnesota,
Minneapolis, MN
SCA-10 6855497 Baylor College of Medicine, Houston, TX
Friedrichs
Ataxia
(Frataxin)
6150091 Baylor College of Medicine, Houston, TX,
INSERM, Paris, France
Aprataxin 7119186 Athena Diagnostics, Inc., Worcester, MA

Athena Diagnostics controls 11 patents (in bold) for 6 tests for hereditary ataxia by exclusive licenses. It also holds a non-exclusive license to US6855497 for SCA-10 testing. Additional patents for SCA-2 (US6623927, US6673535 and US6844431) were found in our search that Athena does not appear to have licensed.